Cargando…
The Serial Engagement Model 17 Years After: From TCR Triggering to Immunotherapy
More than 15 years ago the serial engagement model was proposed as an attempt to solve the low affinity/high sensitivity paradox of TCR antigen recognition. Since then, the model has undergone ups and downs marked by the technical and conceptual advancements made in the field of T lymphocyte activat...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428561/ https://www.ncbi.nlm.nih.gov/pubmed/22973273 http://dx.doi.org/10.3389/fimmu.2012.00272 |
_version_ | 1782241703411843072 |
---|---|
author | Valitutti, Salvatore |
author_facet | Valitutti, Salvatore |
author_sort | Valitutti, Salvatore |
collection | PubMed |
description | More than 15 years ago the serial engagement model was proposed as an attempt to solve the low affinity/high sensitivity paradox of TCR antigen recognition. Since then, the model has undergone ups and downs marked by the technical and conceptual advancements made in the field of T lymphocyte activation. Here, I describe the development of the model and survey recent literature providing evidence either for or against the idea that serial TCR/pMHC engagement might contribute to T lymphocyte activation. I also discuss how the concept of serial TCR engagement might be useful in the design of immunotherapeutic approaches aimed at potentiating T lymphocyte responses in vivo. |
format | Online Article Text |
id | pubmed-3428561 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Frontiers Research Foundation |
record_format | MEDLINE/PubMed |
spelling | pubmed-34285612012-09-12 The Serial Engagement Model 17 Years After: From TCR Triggering to Immunotherapy Valitutti, Salvatore Front Immunol Immunology More than 15 years ago the serial engagement model was proposed as an attempt to solve the low affinity/high sensitivity paradox of TCR antigen recognition. Since then, the model has undergone ups and downs marked by the technical and conceptual advancements made in the field of T lymphocyte activation. Here, I describe the development of the model and survey recent literature providing evidence either for or against the idea that serial TCR/pMHC engagement might contribute to T lymphocyte activation. I also discuss how the concept of serial TCR engagement might be useful in the design of immunotherapeutic approaches aimed at potentiating T lymphocyte responses in vivo. Frontiers Research Foundation 2012-08-28 /pmc/articles/PMC3428561/ /pubmed/22973273 http://dx.doi.org/10.3389/fimmu.2012.00272 Text en Copyright © 2012 Valitutti. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc. |
spellingShingle | Immunology Valitutti, Salvatore The Serial Engagement Model 17 Years After: From TCR Triggering to Immunotherapy |
title | The Serial Engagement Model 17 Years After: From TCR Triggering to Immunotherapy |
title_full | The Serial Engagement Model 17 Years After: From TCR Triggering to Immunotherapy |
title_fullStr | The Serial Engagement Model 17 Years After: From TCR Triggering to Immunotherapy |
title_full_unstemmed | The Serial Engagement Model 17 Years After: From TCR Triggering to Immunotherapy |
title_short | The Serial Engagement Model 17 Years After: From TCR Triggering to Immunotherapy |
title_sort | serial engagement model 17 years after: from tcr triggering to immunotherapy |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428561/ https://www.ncbi.nlm.nih.gov/pubmed/22973273 http://dx.doi.org/10.3389/fimmu.2012.00272 |
work_keys_str_mv | AT valituttisalvatore theserialengagementmodel17yearsafterfromtcrtriggeringtoimmunotherapy AT valituttisalvatore serialengagementmodel17yearsafterfromtcrtriggeringtoimmunotherapy |